Bristol-Myers Squibb Co. (BMY) PT Lowered to $61 at UBS
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $75.57 +1.49%
Rating Summary:
13 Buy, 14 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 40 | New: 22
Rating Summary:
13 Buy, 14 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 40 | New: 22
Join SI Premium – FREE
UBS analyst Colin Bristow lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $61.00 (from $66.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) and 2seventy (TSVT) Report Positive Topline Results from KarMMa-3 Trial
- JAPAN POST BANK Co.,Ltd (7182:JP) (JPSTF) PT Raised to JPY1,080 at Nomura/Instinet
- Yageo Corp. (2327:TT) (YAGOY) PT Lowered to NT$597 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
